• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Eisai Inc. - Strategic SWOT Analysis Review

  • ID: 1495870
  • June 2015
  • 32 pages
  • GlobalData

FEATURED COMPANIES

  • Abraxis BioScience, Inc.
  • Adlyfe Inc.
  • AstraZeneca PLC
  • Ceregene, Inc.
  • MORE

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abraxis BioScience, Inc.
  • Adlyfe Inc.
  • AstraZeneca PLC
  • Ceregene, Inc.
  • MORE

List of Tables
List of Figures
Section 1 - About the Company
Eisai Inc. - Key Facts
Eisai Inc. - Key Employees
Eisai Inc. - Key Employee Biographies
Eisai Inc. - Major Products and Services
Eisai Inc. - History
Eisai Inc. - Company Statement
Eisai Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Eisai Inc. - Business Description
Eisai Inc. - SWOT Analysis
SWOT Analysis - Overview
Eisai Inc. - Strengths
Strength - Strong In-house Research Expertise
Strength - Product Collaboration with Leading Players
Strength - Marketed Products
Eisai Inc. - Weaknesses
Weakness - Weak Financial Performance
Eisai Inc. - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Orphan Drug Designation
Opportunity - Rising Healthcare Expenditure in the US
Eisai Inc. - Threats
Threat - Intense Competition
Threat - Litigation Claims
Threat - Stringent Government Regulations
Eisai Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Eisai Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 01, 2015: Ivor Macleod Appointed Senior Vice President, Chief Financial Officer and Chief Compliance Officer of Eisai
Apr 09, 2015: Eisai Realigns U.S. Operations
Oct 24, 2014: Eisai Launches Search for the Next Medikidz Star Contest for Kids Living With Epilepsy
Oct 13, 2014: Eisai Launches New Online Resource Helping Women Living with Metastatic Breast Cancer Navigate Their Journey
Jun 13, 2014: Eisai Sponsors the Epilepsy Foundation of Metropolitan New York's 2nd Annual Epilepsy Awareness Day at Citi Field
May 14, 2014: Eisai Highlights New Research at 50th ASCO Annual Meeting
Mar 10, 2014: Eisai Announces Retirement of President and CEO
Section 5 – Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Eisai Inc., Key Facts
Eisai Inc., Key Employees
Eisai Inc., Key Employee Biographies
Eisai Inc., Major Products and Services
Eisai Inc., History
Eisai Inc., Other Locations
Eisai Inc., Subsidiaries
Eisai Inc., Key Competitors
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Eisai Inc., Recent Deals Summary

List of Figures
Eisai Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Eisai Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown

Abraxis BioScience, Inc.
Salix Pharmaceuticals, Ltd.
AstraZeneca PLC
Koronis Pharmaceuticals, Inc.
Predictive Biosciences, Inc.
Ceregene, Inc.
Adlyfe Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Grifols, S.A. Takeda Pharmaceutical Company Limited Alexion Pharmaceuticals Teva Pharmaceutical Industries Ltd. Endo International Plc. Essilor International S.A.